Last May, a leading Australian health institute, Menzies School of Health Research, was awarded a grant of up to £4million by the Fleming Fund to improve laboratory diagnostic capacity and antimicrobial data use in Timor-Leste.
Fleming Fund Country Grant in Timor-Leste announced!
Menzies School of Health Research (Menzies) has been awarded a Fleming Fund Country Grant to support testing and surveillance for antimicrobial resistance (AMR) in Timor-Leste.
Menzies have a strong track record of partnering with the Timor-Leste Ministry of Health to strengthen capacity for diagnosis, surveillance and response to infectious disease in country. Therefore, the Fleming Fund Country Grant will build on activity that is currently being undertaken and support the national health laboratory and the vet diagnostic laboratory to build sustainable capacity for AMR identification.
Menzies’ researchers will support the Ministry of Health to use the data generated and work with hospitals and clinicians to help choose the best antibiotics so that people get the best chance of recovering from serious infections, without causing more resistance.
Menzies will also work with the government of Timor-Leste to develop systems for monitoring rates of infections and the use of antibiotics, this will help identify areas where antimicrobial use could be optimised across both the human health and animal health sectors. The one-health approach is critical to contribute to global efforts to fight AMR.
"We look forward to working in partnership with Menzies to improve AMR surveillance in Timor-Leste and help address a leading public health threat"
More Like This
The power of investing in people: how collaboration and communication are changing diagnostic capacity in Timor-Leste
Following the publication of our [Phase I Report](https://www.flemingfund.org/publications/the-fleming-fund-phase-i-a-summary/) on Tuesday 26th April, the Fleming Fund hosted a launch event the following Wednesday. The aim of the launch event was to announce HMG approval for the Fleming Fund until 2025, showcase our new publication and share our partners’ work.